CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −13,042 | $1.75 | $23K | 17,298 |
| 2023-01-04 | Bertrand William C JR Chief Operating Officer | Sale | −3,584 | $1.69 | $6K | 5,781 |
| 2023-01-04 | Lunger John Chief Patient Supply Officer | Sale | −1,100 | $1.69 | $2K | 1,725 |
| 2023-01-04 | Norry Elliot Chief Medical Officer | Sale | −876 | $1.69 | $1K | 1,361 |
| 2023-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −5,073 | $1.69 | $9K | 6,631 |
| 2022-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,536 | $1.97 | $5K | 3,316 |
| 2022-08-01 | Lunger John Chief Patient Supply Officer | Sale | −2,983 | $1.77 | $5K | 4,829 |
| 2022-08-01 | Piccina Cintia Chief Commercial Officer | Sale | −21,040 | $1.77 | $37K | 34,824 |
| 2022-07-05 | Lunger John Chief Patient Supply Officer | Sale | −1,973 | $1.68 | $3K | 3,104 |
| 2022-06-27 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,562 | $1.63 | $4K | 3,290 |
| 2022-01-18 | Bertrand William C JR Chief Operating Officer | Sale | −4,368 | $3.19 | $14K | 7,336 |
| 2022-01-18 | Lunger John Chief Patient Supply Officer | Sale | −4,368 | $3.19 | $14K | 7,336 |
| 2022-01-18 | Norry Elliot Chief Medical Officer | Sale | −2,121 | $3.19 | $7K | 3,529 |
| 2022-01-18 | Rawcliffe Adrian Chief Executive Officer | Sale | −11,096 | $3.19 | $35K | 12,312 |
| 2022-01-12 | Bertrand William C JR Chief Operating Officer | Sale | −2,248 | $3.54 | $8K | 3,754 |
| 2022-01-12 | Lunger John Chief Patient Supply Officer | Sale | −1,076 | $3.54 | $4K | 1,749 |
| 2022-01-12 | Norry Elliot Chief Medical Officer | Sale | −854 | $3.54 | $3K | 1,383 |
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −3,046 | $3.54 | $11K | 3,356 |
| 2022-01-11 | Bertrand William C JR Chief Operating Officer | Sale | −3,770 | $3.56 | $13K | 6,343 |
| 2022-01-11 | Lunger John Chief Patient Supply Officer | Sale | −3,770 | $3.56 | $13K | 6,343 |
Page 4 of 7 · 140 trades